Usefulness of Cardiac Resynchronization Therapy in Patients With Adriamycin-Induced Cardiomyopathy

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 522-526

  Rickard, John ^a   Kumbhani, Dharam J ^a   Baranowski, Bryan ^a   Martin, David O ^a   Tang, Wilson H ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXORUBICIN; HYDRALAZINE; NITRATE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL FEATURE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; NEOPLASM; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARDIOMYOPATHIES; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DOXORUBICIN; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 75349095576     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.024     Document Type: Article

References (16)

1. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., Demets D., White B.G., DeVries D.W., Feldman A.M., Comparison of Medical Therapy, Pacing, and and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
2. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
3. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Fisher W.G., Ellestad M., Messenger J., Kruger K., Hilpisch K.E., Hill M.R., and Multicenter InSync Randomized Clinical Evaluation (MIRACLE) study group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
4. Beashai J.F., Grimm R.A., Nagueh S.F., Baker II J.H., Grennberg S.M., Pires L.A., Tchou P.J., and RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 357 (2007) 2461-2471
5. Parsons L.S. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS (Users Group International Conference). http://www2.sas.com/proceedings/sugi26/p214-26.pdf Accessed September 16, 2009
6. Goorin A.M., Borow K.M., Goldman A., Williams R.G., Henderson I.C., Sallan S.E., Cohen H., and Jaffe N. Congestive heart failure due to Adriamycin cardiotoxicity: its natural history in children. Cancer 47 (1981) 2810-2816
7. Youssef G., and Links M. The prevention and management of cardiovascular complications of chemotherapy in patients with cancer. Am J Cardiovasc Drugs 5 (2005) 233-243
8. Swain S.M., Whaley F.S., and Ewer M.S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97 (2003) 2869-2879
9. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., and Kasper E.K. Underlying causes of long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
10. Appel J.M., Nielsen D., Zerahn B., Jensen B.V., and Skagen K. Anthracycline-induced chronic cardiotoxicity and heart failure. Acta Oncol 46 (2007) 576-580
11. Lefrak E.A., Pitha J., Rosenheim S., and Gottleib J.A. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer 32 (1973) 302-314
12. Cardinale D., Alessandro C., and Cipolla C.M. Prevention and treatment of cardiomyopathy and heart failure in patients receiving cancer chemotherapy. Curr Treat Options Cardiovasc Med 10 (2008) 486-495
13. Jones B.O., Davis A.M., Alison J., Weintraub R.G., Butt W., and Cheung M. Cardiac resynchronization therapy in a child with severe anthracycline-induced congestive heart failure and normal QRS duration. J Heart Lung Transplant 26 (2007) 1333-1335
14. Ajijola O.A., Nandigam K.V., Chabner B.A., Orencole M., Dec G.W., Ruskin J.N., and Singh J. Usefulness of cardiac resynchronization therapy in the management of doxorubicin-induced cardiomyopathy. Am J Cardiol 101 (2008) 1371-1372
15. Spragg D.D., and Kass D.A. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 49 (2006) 26-41
16. van Oosterhout M.F., Arts T., Bassingthwaighte J.B., Reneman R.S., and Prinzen F.W. Relation between local myocardial growth and blood flow during chronic ventricular pacing. Cardiovasc Res 53 (2002) 831-840